Positron Emission Tomography-Based Response to Target and Immunotherapies in Oncology

2-deoxy-2-[(18)F]fluoro-D-glucose ([(18)F]FDG) is a promising tool to support the evaluation of response to either target therapies or immunotherapy with immune checkpoint inhibitors both in clinical trials and, in selected patients, at the single patient’s level. The present review aims to discuss...

Descripción completa

Detalles Bibliográficos
Autores principales: Donegani, Maria Isabella, Ferrarazzo, Giulia, Marra, Stefano, Miceli, Alberto, Raffa, Stefano, Bauckneht, Matteo, Morbelli, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466359/
https://www.ncbi.nlm.nih.gov/pubmed/32722205
http://dx.doi.org/10.3390/medicina56080373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466359/
https://www.ncbi.nlm.nih.gov/pubmed/32722205
http://dx.doi.org/10.3390/medicina56080373

Ejemplares similares